Efavirenz Market

Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
Efavirenz Market contains market size and forecasts of Efavirenz in global, including the following market information:
Global Efavirenz Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Efavirenz Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Efavirenz companies in 2021 (%)
The global Efavirenz market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Efavirenz Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Efavirenz include Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero, Strides Pharma and Gilead Sciences. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Efavirenz manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Efavirenz Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Efavirenz Market Segment Percentages, by Type, 2021 (%)
Single Efavirenz
Two-drug combination
Three-drug combination
Global Efavirenz Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Efavirenz Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Global Efavirenz Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Efavirenz Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Efavirenz revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Efavirenz revenues share in global market, 2021 (%)
Key companies Efavirenz sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Efavirenz sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences